GS-9911

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS-9911, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors [Phase 1]